Loading organizations...
Vaud develops and markets a comprehensive range of health supplements, offering meticulously formulated vitamins and minerals designed to support various bodily functions. The company emphasizes a scientific approach, drawing inspiration from stringent Swiss quality standards to ensure purity and precision in its product development. Its extensive catalog addresses diverse health needs, including immunity, energy, sleep, mental focus, and specialized support for skin, hair, and joints.
Founded in 2021, Vaud emerged from an insight into the growing demand for trusted, high-quality nutritional support. The company aimed to bridge a market gap by providing transparently developed supplements that leverage scientific research and maintain rigorous production benchmarks. This foundation enabled Vaud to establish a brand centered on reliability and efficacy in the competitive wellness sector.
The company serves a broad customer base, including individuals proactively managing their health, those with specific dietary requirements, and consumers seeking targeted nutritional assistance for well-being. Vaud's long-term vision centers on becoming a leading provider of science-backed supplements, continuously expanding its product lines while upholding its commitment to quality and consumer confidence in health optimization.
Vaud has 1 tracked investment across 1 company. The latest tracked deal is $100K Debt in Terapet in November 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 18, 2019 | Terapet | $100K Debt | Vaud | — |